<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Hygiene and Sanitation</journal-id><journal-title-group><journal-title xml:lang="en">Hygiene and Sanitation</journal-title><trans-title-group xml:lang="ru"><trans-title>Гигиена и санитария</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0016-9900</issn><issn publication-format="electronic">2412-0650</issn><publisher><publisher-name xml:lang="en">Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">640273</article-id><article-id pub-id-type="doi">10.47470/0016-9900-2020-99-9-1016-1021</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>EXPERIMENTAL INVESTIGATIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Metabolic changes on the background of acute exposure to paracetamol and evaluation of the effectiveness of hepatoprotective drug</article-title><trans-title-group xml:lang="ru"><trans-title>Метаболические изменения при остром воздействии парацетамолом и оценка эффективности гепатопротективных препаратов</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2435-6936</contrib-id><name-alternatives><name xml:lang="en"><surname>Timasheva</surname><given-names>Gulnara V.</given-names></name><name xml:lang="ru"><surname>Тимашева</surname><given-names>Гульнара Вильевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Ph.D.. Leading researcher, Department of Toxicology and Genetics with an experimental clinic of laboratory animals Ufa Research Institute of Occupational Health and Human Ecology, Ufa, 450106, Russian Federation.</p><p>e-mail: gulnara-vt60@yandex.ru</p></bio><bio xml:lang="ru"><p>Кандидат биол. наук, вед. науч. сотр. отдела токсикологии и генетики с экспериментальной клиникой лабораторных животных ФБУН «Уфимский НИИ медицины труда и экологии человека», 450106, Уфа.</p><p>e-mail: gulnara-vt60@yandex.ru</p></bio><email>gulnara-vt60@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0039-6757</contrib-id><name-alternatives><name xml:lang="en"><surname>Karimov</surname><given-names>D. O.</given-names></name><name xml:lang="ru"><surname>Каримов</surname><given-names>Д. О.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8798-0846</contrib-id><name-alternatives><name xml:lang="en"><surname>Repina</surname><given-names>E. F.</given-names></name><name xml:lang="ru"><surname>Репина</surname><given-names>Э. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7957-2399</contrib-id><name-alternatives><name xml:lang="en"><surname>Smolyankin</surname><given-names>D. A.</given-names></name><name xml:lang="ru"><surname>Смолянкин</surname><given-names>Д. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5596-8180</contrib-id><name-alternatives><name xml:lang="en"><surname>Khusnutdinova</surname><given-names>N. Yu.</given-names></name><name xml:lang="ru"><surname>Хуснутдинова</surname><given-names>Н. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7456-4787</contrib-id><name-alternatives><name xml:lang="en"><surname>Mukhammadieva</surname><given-names>G. F.</given-names></name><name xml:lang="ru"><surname>Мухаммадиева</surname><given-names>Г. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1856-3173</contrib-id><name-alternatives><name xml:lang="en"><surname>Baygildin</surname><given-names>S. S.</given-names></name><name xml:lang="ru"><surname>Байгильдин</surname><given-names>С. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Ufa Research Institute of Occupational Health and Human Ecology</institution></aff><aff><institution xml:lang="ru">ФБУН «Уфимский научно-исследовательский институт медицины труда и экологии человека»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-09-20" publication-format="electronic"><day>20</day><month>09</month><year>2020</year></pub-date><volume>99</volume><issue>9</issue><issue-title xml:lang="ru"/><fpage>1016</fpage><lpage>1021</lpage><history><date date-type="received" iso-8601-date="2024-10-29"><day>29</day><month>10</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Timasheva G.V., Karimov D.O., Repina E.F., Smolyankin D.A., Khusnutdinova N.Y., Mukhammadieva G.F., Baygildin S.S.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Тимашева Г.В., Каримов Д.О., Репина Э.Ф., Смолянкин Д.А., Хуснутдинова Н.Ю., Мухаммадиева Г.Ф., Байгильдин С.С.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Timasheva G.V., Karimov D.O., Repina E.F., Smolyankin D.A., Khusnutdinova N.Y., Mukhammadieva G.F., Baygildin S.S.</copyright-holder><copyright-holder xml:lang="ru">Тимашева Г.В., Каримов Д.О., Репина Э.Ф., Смолянкин Д.А., Хуснутдинова Н.Ю., Мухаммадиева Г.Ф., Байгильдин С.С.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2021-10-20"/></permissions><self-uri xlink:href="https://journals.eco-vector.com/0016-9900/article/view/640273">https://journals.eco-vector.com/0016-9900/article/view/640273</self-uri><abstract xml:lang="en"><p><italic><bold>Introduction.</bold> In modern conditions, caused by the pandemic of a new type of viral infection Covid 19, the use of paracetamol, which has hepatotoxic properties in overdose, has increased. It seems relevant to study metabolic disorders in the liver in acute paracetamol intoxication and evaluate the effectiveness of the timely use of hepatoprotective drugs. </italic></p><p><italic><bold>The purpose of this study</bold> is an experimental assessment of metabolic changes at the early stages of paracetamol exposure and pharmacological correction of toxic liver lesions with oxymethyluracil in comparison with known hepatoprotectors – ademetionine and Mexidol.</italic></p><p><italic><bold>Material and methods.</bold> Acute intragastric administration of paracetamol to laboratory animals was performed, and the corrective effect of the drug oxymethyluracil was studied in comparison with “Heptor” and “Mexidol”. Biochemical studies of biomaterial of laboratory animals were conducted.</italic></p><p><italic><bold>Results.</bold> The analysis found the use of known hepatoprotectors and oxymethyluracil after exposure to paracetamol to normalize the biochemical parameters that characterize the functional state of the liver in laboratory animals.</italic></p><p><italic><bold>Conclusion.</bold> Oxymethyluracil, along with known hepatoprotectors, has a protective effect on the liver of laboratory animals under acute exposure to paracetamol comparable to, and in some cases exceeding, the corrective action of “Heptor” and “Mexidol”.</italic></p></abstract><trans-abstract xml:lang="ru"><p><italic><bold>Введение.</bold> В современных условиях, вызванных пандемией нового вида вирусной инфекции COVID-19, возросло применение парацетамола, обладающего гепатотоксическими свойствами при передозировке. Представляется актуальным изучение метаболических нарушений в печени при острой интоксикации парацетамолом и оценка эффективности своевременного применения гепатопротективных препаратов.</italic></p><p><italic><bold>Цель настоящего исследования </bold>– экспериментальная оценка метаболических изменений на ранних сроках воздействия парацетамола и фармакологическая коррекция токсических поражений печени оксиметилурацилом в сравнении с известными гепатопротекторами – «Гептором» и «Мексидолом».</italic></p><p><italic><bold>Материал и методы.</bold> Проведено острое внутрижелудочное введение парацетамола лабораторным животным, изучено корректирующее действие препарата оксиметилурацила в сравнении с «Гептором» и «Мексидолом». Проведены биохимические исследования биоматериала лабораторных животных.</italic></p><p><italic><bold>Результаты.</bold> По результатам анализа установлено, что при применении известных гепатопротекторов и оксиметилурацила после воздействия парацетамолом происходит нормализация биохимических показателей, характеризующих функциональное состояние печени у лабораторных животных.</italic></p><p><italic><bold>Заключение.</bold> Оксиметилурацил наряду с известными гепатопротекторами оказывает защитное действие на печень лабораторных животных при остром воздействии парацетамолом, сопоставимое, а в некоторых случаях и превышающее корректирующее действие препаратов «Гептор» и «Мексидол».</italic></p></trans-abstract><kwd-group xml:lang="en"><kwd>acute toxic liver damage</kwd><kwd>paracetamol</kwd><kwd>hepatoprotective effect</kwd><kwd>heptor (ademetionin)</kwd><kwd>ethylmethylhydroxypyridine succinate</kwd><kwd>oxymethyluracil</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>острое токсическое поражение печени</kwd><kwd>парацетамол</kwd><kwd>гепатопротекторное действие</kwd><kwd>«Гептор»</kwd><kwd>«Мексидол»</kwd><kwd>оксиметилурацил</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Ramenskaya G.V., Pilipovich A.A. Combination medication in the therapy of pain syndrome. Russkiy meditsinskiy zhurnal. 2017; 20(4): 1006–13. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Раменская Г.В., Пилипович А.А. Комбинированный препарат в терапии болевого синдрома. Русский медицинский журнал. 2017; 20(4): 1006-13</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Jóźwiak-Bebenista M., Nowak J.Z. Paracetamol: mechanism of action, applications and safety concern. Acta Pol. Pharm. 2014; 71(1): 11–23.</mixed-citation><mixed-citation xml:lang="ru">Hazai E., Monostory K., Bakos A., Zacher G., Vereczkey L. About paracetamol again. Orv. Hetil. 2001; 142(7): 345-90. (in Hu)</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Hazai E., Monostory K., Bakos A., Zacher G., Vereczkey L. About paracetamol again. Orv. Hetil. 2001; 142(7): 345–90. (in Hu)</mixed-citation><mixed-citation xml:lang="ru">State register of medicines. Available at: http://grls.rosminzdrav.ru/grls.aspx (in Russian)</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">State register of medicines. Available at: http://grls.rosminzdrav.ru/grls.aspx (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Государственный реестр лекарственных средств. Available at: http://grls.rosminzdrav.ru/grls.aspx</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Sarrell E.M., Wielunsky E., Cohen H.A. Antipyretic treatment in young children with fever: acetaminophen, ibuprofen, or both alternating in a randomized, double-blind study. Arch. Pediatr. Adolesc. Med. 2006; 160(2): 197–202. https://doi.org/10.1001/archpedi.160.2.197</mixed-citation><mixed-citation xml:lang="ru">Sarrell E.M., Wielunsky E., Cohen H.A. Antipyretic treatment in young children with fever: acetaminophen, ibuprofen, or both alternating in a randomized, double-blind study. Arch. Pediatr. Adolesc. Med. 2006; 160(2): 197-202. https://doi.org/10.1001/archpedi.160.2.197</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><mixed-citation>Hollinghurst S., Redmond N., Costelloe C., Montgomery A., Fletcher M., Peters T.J., et al. Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): economic evaluation of a randomized controlled trial. BMJ. 2008; 337: a1490. https://doi.org/10.1136/bmj.a1490</mixed-citation></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Tanatarov S.Z. Parenteral administration of paracetamol for improve of anesthesia in surgical oncology. Vestnik Avitsenny. 2012; (2): 84–7. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Танатаров С.З. Парентеральное применение парацетамола для совершенствования анестезии в онкохирургии. Вестник Авиценны. 2012; (2): 84-7</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Kalantzi L., Reppas C., Dressman J.B., Amidon G.L., Junginger H.E., Midha K.K., et al. Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol). J. Pharm. Sci. 2006; 95(1): 4–14. https://doi.org/10.1002/jps.20477</mixed-citation><mixed-citation xml:lang="ru">Kalantzi L., Reppas C., Dressman J.B., Amidon G.L., Junginger H.E., Midha K.K., et al. Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol). J. Pharm. Sci. 2006; 95(1): 4-14. https://doi.org/10.1002/jps.20477</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Brune K., Renner B., Tiegs G. Acetaminophen/paracetamol: a history of errors, failures and false decisions. Eur. J. Pain. 2015; 19(7): 953–65. https://doi.org/10.1002/ejp.621</mixed-citation><mixed-citation xml:lang="ru">Brune K., Renner B., Tiegs G. Acetaminophen/paracetamol: a history of errors, failures and false decisions. Eur. J. Pain. 2015; 19(7): 953-65. https://doi.org/10.1002/ejp.621</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Eremina E.Yu. Drug damage to the liver. Prakticheskaya meditsina. 2014; 77(1): 20–9. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Еремина Е.Ю. Лекарственные поражения печени. Практическая медицина. 2014; 77(1): 20-9</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Bunchorntavakul С., Reddy K.R. Acetaminophen (APAP or N-acetyl-p-aminophenol) and acute liver failure. Clin. Liver Dis. 2018; 22(2): 325–46. https://doi.org/10.1016/j.cld.2018.01.007</mixed-citation><mixed-citation xml:lang="ru">Bunchorntavakul С., Reddy K.R. Acetaminophen (APAP or N-acetyl-p-aminophenol) and acute liver failure. Clin. Liver Dis. 2018; 22(2): 325-46. https://doi.org/10.1016/j.cld.2018.01.007</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Bunchorntavaku C., Reddy K.R. Acetaminophen-related hepatotoxicity. Clin. Liver Dis. 2013; 17(4): 587–607. https://doi.org/10.1016/j.cld.2013.07.005</mixed-citation><mixed-citation xml:lang="ru">Bunchorntavaku C., Reddy K.R. Acetaminophen-related hepatotoxicity. Clin. Liver Dis. 2013; 17(4): 587-607. https://doi.org/10.1016/j.cld.2013.07.005</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Wang X., Wu Q., Liu A., Anadón A., Rodríguez J.L., Martínez-Larrañaga M.R., et al. Paracetamol: overdose-induced oxidative stress toxicity, metabolism, and protective effects of various compounds in vivo and in vitro. Drug. Metab. Rev. 2017; 49(4): 395–437. https://doi.org/10.1080/03602532.2017.1354014</mixed-citation><mixed-citation xml:lang="ru">Wang X., Wu Q., Liu A., Anadón A., Rodríguez J.L., Martínez-Larrañaga M.R., et al. Paracetamol: overdose-induced oxidative stress toxicity, metabolism, and protective effects of various compounds in vivo and in vitro. Drug. Metab. Rev. 2017; 49(4): 395-437. https://doi.org/10.1080/03602532.2017.1354014</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Xu X.Y., Hu J.N., Liu Z., Zhang R., He Y.F., Hou W., et al. Saponins (ginsenosides) from the leaves of Panax quinquefolius ameliorated acetaminophen-induced hepatotoxicity in mice. J. Agric. Food Chem. 2017; 65(18): 3684–92. https://doi.org/10.1021/acs.jafc.7b00610</mixed-citation><mixed-citation xml:lang="ru">Xu X.Y., Hu J.N., Liu Z., Zhang R., He Y.F., Hou W., et al. Saponins (ginsenosides) from the leaves of Panax quinquefolius ameliorated acetaminophen-induced hepatotoxicity in mice. J. Agric. Food Chem. 2017; 65(18): 3684-92. https://doi.org/10.1021/acs.jafc.7b00610</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><mixed-citation>Subramanya S.B., Venkataraman B., Meeran M.F.N., Goyal S.N., Patil C.R., Ojha S. Therapeutic potential of plants and plant derived phytochemicals against acetaminophen-induced liver injury. Int. J. Mol. Sci. 2018; 19(12): 3776. https://doi.org/10.3390/ijms19123776</mixed-citation></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Voronina T.A., Smirnov L.D., Dyumaev K.M. Actual directions of use of Mexidol. In: Proceedings of the National Scientific and Practical Conference «Free Radicals, Antioxidants and Human Diseases» [Sbornik trudov natsional’noy nauchno-prakticheskoy konferentsii «Svobodnye radikaly, antioksidanty i bolezni cheloveka»]. Smolensk; 2001: 191–2. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Воронина Т.А., Смирнов Л.Д., Дюмаев К.М. Актуальные направления применения мексидола. В кн.: Сборник трудов национальной научно-практической конференции «Свободные радикалы, антиоксиданты и болезни человека». Смоленск; 2001: 191-2.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Zhang F., Gu J.X., Zou X.P., Zhuge Y.Z. Protective effects of S-adenosylmethionine against CCl4 – and ethanol-induced experimental hepatic fibrosis. Molekulyarnaya biologiya. 2016; 50(2): 284–90. https://doi.org/10.7868/S0026898416020270 (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Zhang F., Gu J.X., Zou X.P., Zhuge Y.Z. Протективные эффекты S-аденозилметионина при экспериментальном фиброзе печени, индуцированном ccl4 и этанолом. Молекулярная биология. 2016; 50(2): 284-90. https://doi.org/10.7868/S0026898416020270</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Gong Z., Yan S., Zhang P., Huang Y., Wang L. Effects of S-adenosylmethionine on liver methionine metabolism and steatosis with ethanol-induced liver injury in rats. Hepatol. Int. 2008; 2(3): 346–52. https://doi.org/10.1007/s12072-008-9082-1</mixed-citation><mixed-citation xml:lang="ru">Gong Z., Yan S., Zhang P., Huang Y., Wang L. Effects of S-adenosylmethionine on liver methionine metabolism and steatosis with ethanol-induced liver injury in rats. Hepatol. Int. 2008; 2(3): 346-52. https://doi.org/10.1007/s12072-008-9082-1</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Katikova O.Yu. The effect of mexidol on the state of homeostasis and lipid peroxidation in guinea pigs intoxicated with paracetamol. Eksperimental’naya i klinicheskaya farmakologiya. 2002; 65(6): 53–6. https://doi.org/10.30906/0869-2092-2002-65-6-53-56 (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Катикова О.Ю. Влияние мексидола на состояние гомеостаза и перекисное окисление липидов при интоксикации парацетамолом. Экспериментальная и клиническая фармакология. 2002; 65(6): 53-6. https://doi.org/10.30906/0869-2092-2002-65-6-53-56</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Myshkin V.A., Bakirov A.B. Oxymethyluracil [Oksimetiluratsil]. Ufa: DAR; 2001. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Мышкин В.А., Бакиров А.Б. Оксиметилурацил. Уфа: ДАР; 2001.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Myshkin V.A., Bakirov A.B., Repina E.F., Karimov D.O. Experimental Pharmacocorrection of Toxic Liver Damage with Antioxidants [Eksperimental’naya farmakokorrektsiya toksicheskikh porazheniy pecheni antioksidantami]. Ufa: Print-2; 2016. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Мышкин В.А., Бакиров А.Б., Репина Э.Ф., Каримов Д.О. Экспериментальная фармакокоррекция токсических поражений печени антиоксидантами. Уфа: Принт-2; 2016.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Myshkin V.A., Enikeev D.A., Srubilin D.A., Gimadieva A.R. Experimental evaluation of pyrimidine derivatives using models of the toxically damaged liver: a review. Meditsinskie nauki. 2016; (3): 88–98. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Мышкин В.А., Еникеев Д.А., Срубилин Д.А., Гимадиева А.Р. Экспериментальная оценка производных пиримидина на моделях токсического поражения печени: обзор. Научное обозрение. Медицинские науки. 2016; (3): 88-98.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Repina E.F., Myshkin V.A., Karimov D.O., Timasheva G.V., Khusnutdinova N.Yu., Smolyankin D.A., et al. Antihypoxic activity of the complex compound of oxymethyluracil with ascorbic acid. Toksikologicheskiy vestnik. 2018; 151(4): 20–3. https://doi.org/10.36946/0869-7922-2018-4-20-23 (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Репина Э.Ф., Мышкин В.А., Каримов Д.О., Тимашева Г.В., Хуснутдинова Н.Ю., Смолянкин Д.А. и соавт. Антигипоксическая активность комплексного соединения оксиметилурацила с аскорбиновой кислотой. Токсикологический вестник. 2018; 151(4): 20-3. https://doi.org/10.36946/0869-7922-2018-4-20-23</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Kamyshnikov V.S. Handbook of Clinical and Biochemical Research and Laboratory Diagnostics [Spravochnik po kliniko-biokhimicheskim issledovaniyam i laboratornoy diagnostike]. Moscow: Medpress-infom; 2009. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Камышников В.С. Справочник по клинико-биохимическим исследованиям и лабораторной диагностике. М.: Медпресс-инфом; 2009.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Eremina E.Yu. Drug-induced liver diseases. Prakticheskaya meditsina. 2014; (1): 20–9. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Еремина Е.Ю. Лекарственные поражения печени. Практическая медицина. 2014; (1): 20-9.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Bibik E.Yu., Krivokolysko B.S., Burdeynaya A.A., Demenko A.V., Frolov K.A., Dotsenko V.V., et al. Effects of partially hydrogenated pyridines (cyanothioacetamide derivatives) on the blood of rats with combined paracetamol-alcoholic liver injury. Kubanskiy nauchnyy meditsinskiy vestnik. 2019; 26(2): 106–14. https://doi.org/10.25207/1608-6228-2019-26-2-106-114. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Бибик Е.Ю., Кривоколыско Б.С., Бурдейная А.А., Деменко А.В., Фролов К.А., Доценко В.В. и соавт. Влияние частично гидрированных пиридинов, производных цианотиоацетамида, на показатели крови крыс с сочетанным парацетамольно-алкогольным поражением печени. Кубанский научный медицинский вестник. 2019; 26(2): 106-14. https://doi.org/10.25207/1608-6228-2019-26-2-106-114</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Mirsaev T.R. Hepatoprotective activity of oxymethyluracil. Farmatsiya. 2007; (2): 34–5. (in Russia)</mixed-citation><mixed-citation xml:lang="ru">Мирсаев Т.Р. Гепатопротекторное действие оксиметилурацила. Фармация. 2007; (2): 34-5.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Vyshkatalyuk A.B., Semenov V.E., Zobov V.V., Galyametdinova I.V., Gumarova L.F., Parfenov A.A. Synthesis and primary evaluation of the hepatoprotective properties of novel pyrimidine derivatives. Bioorganicheskaya khimiya. 2017; 43(5): 572–80. https://doi.org/10.7868/S0132342317040170 (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Вышкаталюк А.Б., Семенов В.Э., Зобов В.В., Галяметдинова И.В., Гумарова Л.Ф., Парфенов А.А. Синтез и первичная оценка гепатопротектных свойств новых производных пиримидинового ряда. Биоорганическая химия. 2017; 43(5): 572-80. https://doi.org/10.7868/S0132342317040170</mixed-citation></citation-alternatives></ref></ref-list></back></article>
